Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis

被引：0
|
作者：
Barbara Rossi
Giovanni Schinzari
Giulio Maccauro
Laura Scaramuzzo
Diego Signorelli
Michele A Rosa
Carlo Fabbriciani
Barone Carlo
机构：
[1] Catholic University,Department of Orthopaedics and Traumatology
[2] Agostino Gemelli Hospital,Department of Medical Oncology
[3] Catholic University,Department of Orthopaedics
[4] Agostino Gemelli Hospital,undefined
[5] Messina University,undefined
来源：
BMC Musculoskeletal Disorders | / 11卷
关键词：
Vascular Endothelial Growth Factor; Osteosarcoma; Vascular Endothelial Growth Factor Expression; Local Relapse; High Grade Osteosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] NEOADJUVANT HIGH-DOSE METHOTREXATE, CISPLATIN, AND DOXORUBICIN FOR THE MANAGEMENT OF PATIENTS WITH NONMETASTIC OSTEOSARCOMA
    WEINER, MA
    HARRIS, MB
    LEWIS, M
    JONES, R
    SHERRY, H
    FEURER, EJ
    JOHNSON, J
    LAHMAN, E
    CANCER TREATMENT REPORTS, 1986, 70 (12): : 1431 - 1432
  • [12] Pharmacogenetic analysis of high-dose methotrexate treatment in paediatric osteosarcoma
    Hegyi, M.
    Csordas, K.
    Eipel, O.
    Csagoly, E.
    Erdelyi, D. J.
    Semsei, A. F.
    Kovacs, G. T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S353 - S353
  • [13] Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity:: A joint study by the Italian and Scandinavian Sarcoma Groups
    Ferrari, S
    Smeland, S
    Mercuri, M
    Bertoni, F
    Longhi, A
    Ruggieri, P
    Alvegard, TA
    Picci, P
    Capanna, R
    Bernini, G
    Müller, C
    Tienghi, A
    Wiebe, T
    Comandone, A
    Böhling, T
    Del Prever, AB
    Brosjö, O
    Bacci, G
    Sæter, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8845 - 8852
  • [14] Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
    Hegyi, Marta
    Arany, Adam
    Semsei, Agnes F.
    Csordas, Katalin
    Eipel, Oliver
    Gezsi, Andras
    Kutszegi, Nora
    Csoka, Monika
    Muller, Judit
    Erdelyi, Daniel J.
    Antal, Peter
    Szalai, Csaba
    Kovacs, Gabor T.
    ONCOTARGET, 2017, 8 (06) : 9388 - 9398
  • [15] Methotrexate (MTX) serum peak monitoring in patients with osteosarcoma treated with high-dose methotrexate chemotherapy
    Landre, Thierry
    Cras, Audrey
    El Ghessassi, Ibrahim
    Mourez, Thomas
    Martre, Helene Sauvageon
    Faure, Pierre
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 499 - 499
  • [16] Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan
    Kudawara, Ikuo
    Aoki, Yasuaki
    Ueda, Takafumi
    Araki, Nobuhito
    Naka, Norifumi
    Nakanishi, Hirofumi
    Matsumine, Akihiko
    Ieguchi, Makoto
    Mori, Shigeki
    Myoui, Akira
    Kuratsu, Shigeyuki
    Hashimoto, Nobuyuki
    Yoshikawa, Hideki
    JOURNAL OF CHEMOTHERAPY, 2013, 25 (01) : 41 - 48
  • [17] Chemotherapy for osteosarcoma with high-dose methotrexate is effective and outpatient therapy is now possible
    Pete Anderson
    Nature Clinical Practice Oncology, 2007, 4 : 624 - 625
  • [18] Chemotherapy for osteosarcoma with high-dose methotrexate is effective and outpatient therapy is now possible
    Anderson, Pete
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 624 - 625
  • [19] HIGH DOSE METHOTREXATE CHEMOTHERAPY IN OSTEOSARCOMA IN CHILDREN
    WATTS, HG
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1976, 58 (05): : 734 - 734
  • [20] ADRIAMYCIN METHOTREXATE HIGH-DOSE VERSUS ADRIAMYCIN METHOTREXATE MODERATE DOSE AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA OF THE EXTREMITIES - A RANDOMIZED STUDY
    BACCI, G
    GHERLINZONI, F
    PICCI, P
    VANHORN, JR
    JAFFE, N
    GUERRA, A
    RUGGIERI, P
    BIAGINI, R
    CAPANNA, R
    TONI, A
    MERCURI, M
    DALLARI, D
    CAMPANACCI, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (11): : 1337 - 1345
12345